Evidence map›Paper›PMID 36544499›Full record

ArticleFrontiers in medicine2022

A study of the risk factors for phlebitis in patients stratified using the acute physiology and chronic health evaluation II score and admitted to the intensive care unit: A

Yuki Kishihara, Hideto Yasuda, Takashi Moriya, Masahiro Kashiura, Midori Koike, Yuki Kotani, Natsuki Kondo, Kosuke Sekine, Nobuaki Shime, Keita Morikane and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Yuki KishiharaDepartment of Emergency and Critical Care Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Hideto YasudaDepartment of Emergency and Critical Care Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Takashi MoriyaDepartment of Emergency and Critical Care Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Masahiro KashiuraDepartment of Emergency and Critical Care Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Midori KoikeDepartment of Emergency and Critical Care Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Yuki KotaniDepartment of Intensive Care Medicine, Kameda Medical Center, Chiba, Japan.
Natsuki KondoDepartment of Intensive Care Medicine, Chiba Emergency Medical Center, Chiba, Japan.
Kosuke SekineDepartment of Medical Engineer, Kameda Medical Center, Chiba, Japan.
Nobuaki ShimeDepartment of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Keita MorikaneDivision of Clinical Laboratory and Infection Control, Yamagata University Hospital, Yamagata, Japan.
Takayuki AbeBiostatistics, Clinical and Translational Research Center, Keio University School of Medicine, Tokyo, Japan.
Jichi Medical University · JPJichi Medical University Saitama Medical Center · JPKameda Medical Center · JPHiroshima University · JPYamagata University Hospital · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Peripheral intravascular catheters (PIVCs) are inserted in most patients admitted to the intensive care unit (ICU). Previous research has discussed various risk factors for phlebitis, which is one of the complications of PIVCs. However, previous studies have not investigated the risk factors based on the patient's severity of illness, such as the Acute Physiology and Chronic Health Evaluation (APACHE) II score. Different treatments can be used based on the relationship of risk factors to the illness severity to avoid phlebitis. Therefore, in this study, we investigate whether the risk factors for phlebitis vary depending on the APACHE II score. Materials and methods: This study was a Results: A total of 1,251 patients and 3,267 PIVCs were analyzed. Multivariable marginal Cox regression analysis reveals that there were statistically significant differences among the following variables evaluated HR (95%CI): (i) in group 1, standardized drug administration measures (HR, 0.4 [0.17-0.9]; Conclusion: We found that phlebitis risk factors varied according to illness severity. By considering these different risk factors, different treatments may be provided to avoid phlebitis based on the patient's severity of illness.

Indexed as

APACH II scorecathetercritically ill patientintensive care unit (ICU)peripheralphlebitisrisk factors

Identifiers

PMID36544499
PMCPMC9760669
OpenAlexW4310672780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.